Invention Grant
- Patent Title: Thermostable CAS9 nucleases
-
Application No.: US16469683Application Date: 2017-08-16
-
Publication No.: US11976306B2Publication Date: 2024-05-07
- Inventor: John Van Der Oost , Richard Van Kranenburg , Elleke Fenna Bosma , Ioannis Mougiakos , Prarthana Mohanraju
- Applicant: Wageningen Universiteit , Stichting Voor De Technische Wetenschappen
- Applicant Address: NL Wageningen
- Assignee: Stichting Voor De Technische Wetenschappen,WAGENINGEN UNIVERSITEIT
- Current Assignee: Stichting Voor De Technische Wetenschappen,WAGENINGEN UNIVERSITEIT
- Current Assignee Address: NL Utrecht; NL Wageningen
- Agency: Riverside Law LLP
- Priority: WO TEP2016081077 2017.08.16
- International Application: PCT/EP2017/070797 2017.08.16
- International Announcement: WO2018/108339A 2018.06.21
- Date entered country: 2019-06-14
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/10 ; C12N15/11 ; C12N15/113 ; C12N15/90

Abstract:
Thermostable Cas9 nucleases. The present invention relates to the field of genetic engineering and more particularly to nucleic acid editing and genome modification. The present invention provides an isolated Cas protein or polypeptide fragment thereof having an amino acid sequence of SEQ ID NO: 1 or a sequence of at least 77% identity therewith. The Cas protein or polypeptide is capable of binding, cleaving, marking or modifying a double stranded target polynucleotide at a temperature in the range 20° C. and 100° C. inclusive. The invention further provides isolated nucleic acid molecules encoding said Cas9 nucleases, expression vectors and host cells. The invention also provides PAM sequences recognized by the Cas protein or polypeptide, The Cas9 nucleases disclosed herein provide novel tools for genetic engineering in general, in particular at elevated temperatures.
Public/Granted literature
- US20190322993A1 THERMOSTABLE CAS9 NUCLEASES Public/Granted day:2019-10-24
Information query